Skip to main content

Table 1 The DALYs of NASH related liver cancer attributable to HFPG in 1990 and 2019, and its temporal trends from 1990 to 2019

From: Estimates and trends of the global burden of NASH-related liver cancer attributable to high fasting plasma glucose in 1990–2019: analysis of data from the 2019 Global Burden of Disease Study

Characteristics

1990

2019

1990–2019

DALYs cases

No. (95% UI)

ASR per 1000

No. (95% UI)

Percentage (%)

DALYs cases

No. (95% UI)

ASR per 100,000

No. (95% UI)

Percentage (%)

EAPC

No. (95% CI)

Overall

22,814.15 (5224.6–51,824.35)

0.57 (0.13–1.31)

4.77 (1.1–10.38)

60,308.72 (14,610.29–135,326.46)

0.73 (0.18–1.65)

7.59 (1.8–16.02)

0.3 (0.05–0.56)

Socio-demographic index

High SDI

3728.39 (884.31–8399.56)

0.35 (0.08–0.8)

6.18 (1.42–13.24)

15,009.74 (3683.96–33,421.49)

0.80 (0.2–1.78)

9.74 (2.39–20.18)

2.87 (2.62–3.11)

High-middle SDI

6188.13 (1408.76–14,086.36)

0.57 (0.13–1.3)

4.98 (1.13–10.86)

9880.89 (2385.02–22,226.78)

0.48 (0.12–1.08)

7.22 (1.69–15.29)

–1.39 (–1.73––1.05)

Middle SDI

9473.12 (2117.33–21,730.86)

0.93 (0.21–2.11)

4.46 (1.03–9.71)

23,847.28 (5768.12–54,084.87)

0.96 (0.23–2.18)

7.18 (1.69–15.15)

–0.61 (–1.05––0.16)

Low-middle SDI

2573.91 (593.05–5825.6)

0.45 (0.1–1.01)

4.27 (0.98–9.29)

8734.82 (2070.69–19,802.48)

0.65 (0.16–1.48)

7.2 (1.7–15.1)

0.81 (0.6–1.03)

Low SDI

837.44 (192.22–2036.17)

0.38 (0.09–0.92)

3.88 (0.88–8.51)

2800.07 (647.08–6650.46)

0.57 (0.14–1.34)

5.64 (1.33–11.87)

1.24 (1.16–1.33)

Region

Andean Latin America

79.78 (16.55–199.66)

0.42 (0.09–1.06)

4.11 (0.86–9.2)

305.12 (66.59–748.71)

0.56 (0.12–1.38)

7.81 (1.67–16.73)

0.68 (0.33–1.03)

Australasia

31.55 (6.75–77.81)

0.13 (0.03–0.32)

3.92 (0.87–8.62)

304.66 (68.48–717.36)

0.61 (0.14–1.44)

6.94 (1.59–14.89)

5.5 (5.07–5.93)

Caribbean

247.02 (56.82–591.37)

0.96 (0.22–2.28)

8.01 (1.85–16.63)

362.26 (88.96–865.62)

0.7 (0.17–1.67)

10.29 (2.49–21.13)

–0.92 (–1.79––0.04)

Central Asia

69.69 (15.19–179.59)

0.15 (0.03–0.4)

3.45 (0.74–7.58)

666.45 (146.5–1639.07)

0.94 (0.21–2.28)

5.97 (1.34–12.74)

5.71 (5.07–6.34)

Central Europe

820.92 (186.76–1900.68)

0.55 (0.13–1.27)

6.49 (1.44–13.92)

1136.53 (272.8–2739.61)

0.52 (0.12–1.24)

9.8 (2.35–20.21)

0.09 (–0.37–0.55)

Central Latin America

435.56 (102.98–1004.28)

0.55 (0.13–1.27)

7.79 (1.83–16.11)

2033.89 (499.42–4618.83)

0.88 (0.22–1.97)

11.7 (2.87–23.56)

1.73 (1.49–1.97)

Central Sub-Saharan Africa

43.87 (9.12–113.7)

0.21 (0.04–0.52)

3.84 (0.85–8.46)

140.87 (29.16–362.18)

0.28 (0.06–0.69)

5.06 (1.14–10.83)

0.8 (0.71–0.9)

East Asia

11,760.54 (2615.07–27,185.61)

1.3 (0.29–2.99)

4.47 (1.02–9.71)

14,381.59 (3385.91–32,233.35)

0.68 (0.16–1.52)

6.05 (1.37–13.15)

–3.72 (–4.39––3.04)

Eastern Europe

238.55 (52.46–548.58)

0.08 (0.02–0.2)

3.38 (0.73–7.39)

835.38 (192.14–1940.18)

0.24 (0.06–0.55)

4.78 (1.04–10.45)

4.19 (3.92–4.45)

Eastern Sub-Saharan Africa

214.5 (47.29–534.27)

0.31 (0.07–0.77)

3.2 (0.72–7.09)

718.23 (157.7–1750.77)

0.48 (0.11–1.18)

4.16 (0.94–9)

1.35 (1.2–1.5)

High-income Asia Pacific

1239.46 (288.87–2772.63)

0.6 (0.14–1.34)

5.41 (1.23–11.74)

3131.43 (737.54–7239.83)

0.69 (0.16–1.62)

7.41 (1.72–16.08)

–0.34 (–0.97–0.29)

High-income North America

1137.48 (267.93–2483.84)

0.32 (0.08–0.69)

7.72 (1.83–16.2)

6915.45 (1756.89–14,784.65)

1.1 (0.28–2.36)

11.82 (2.94–24.03)

5.54 (5.13–5.96)

North Africa and Middle East

1043.71 (230.45–2623.78)

0.64 (0.14–1.59)

4.7 (1.08–10.3)

6237.91 (1407.41–14,658.2)

1.48 (0.34–3.48)

8.88 (2.18–18.68)

3.41 (3.18–3.63)

Oceania

17.22 (3.82–44.07)

0.61 (0.14–1.55)

7.52 (1.82–15.97)

67.6 (16.83–155.11)

1 (0.26–2.32)

12.6 (3.37–25.29)

1.82 (1.65–1.98)

South Asia

1801.6 (411.07–4093.7)

0.34 (0.08–0.77)

4.51 (1.04–9.79)

8282.17 (2018.13–18,376.16)

0.6 (0.15–1.33)

7.93 (1.93–16.45)

1.77 (1.65–1.9)

Southeast Asia

1388.78 (310.64–3365.4)

0.59 (0.13–1.4)

4.08 (0.93–8.91)

7014.6 (1670.42–16,599.05)

1.25 (0.3–3.01)

7.3 (1.71–15.54)

2.52 (2.43–2.62)

Southern Latin America

68.64 (14.72–173.19)

0.15 (0.03–0.37)

5.55 (1.22–11.94)

369.12 (86.57–867.65)

0.44 (0.1–1.02)

9.51 (2.26–19.73)

4.44 (4.25–4.64)

Southern Sub-Saharan Africa

216.97 (45.54–590.34)

0.83 (0.17–2.24)

4.3 (1–9.35)

831.04 (201.54–1831.98)

1.52 (0.37–3.35)

7.02 (1.67–14.79)

1.72 (1.08–2.36)

Tropical Latin America

161.53 (38.59–355.11)

0.18 (0.04–0.4)

5.85 (1.35–12.46)

673.33 (161.98–1460.64)

0.28 (0.07–0.61)

7.76 (1.83–16.27)

2.18 (1.87–2.5)

Western Europe

1475.54 (334.91–3417.45)

0.25 (0.06–0.57)

6.65 (1.54–14.2)

4823.89 (1145.08–11,045.46)

0.53 (0.13–1.21)

9.9 (2.36–20.64)

2.65 (2.45–2.85)

Western Sub-Saharan Africa

321.24 (70.59–783.6)

0.4 (0.09–0.97)

3.35 (0.77–7.42)

1077.22 (236.93–2607.65)

0.65 (0.15–1.54)

4.92 (1.15–10.62)

1.47 (1.34–1.59)

  1. NASH: nonalcoholic steatohepatitis; HFPG: high fasting plasma glucose; DALYs: disability-adjusted life years; EAPCs: Estimated annual percentage changes; ASR: age standardized rate; SDI: socio-demographic index